Loading...
XSHG
600873
Market cap4.28bUSD
Jul 14, Last price  
10.89CNY
1D
0.93%
1Q
1.11%
Jan 2017
67.02%
Name

MeiHua Holdings Group Co Ltd

Chart & Performance

D1W1MN
P/E
11.19
P/S
1.22
EPS
0.97
Div Yield, %
3.86%
Shrs. gr., 5y
-1.15%
Rev. gr., 5y
11.49%
Revenues
25.07b
-9.69%
404,251,708481,611,158693,405,256865,575,637984,325,3995,015,053,9856,866,208,4687,469,678,1307,780,383,3139,864,967,36111,853,174,31811,092,771,95111,132,161,08212,648,045,80314,553,547,45517,049,514,47522,836,890,32427,937,152,79827,760,612,25925,069,288,294
Net income
2.74b
-13.85%
6,639,1237,913,95411,600,1417,514,71110,987,438790,001,983719,501,893607,832,328403,697,648500,265,738425,456,7651,041,689,9431,173,606,8201,001,546,287988,641,850982,063,5972,402,247,5564,406,241,9813,180,949,6952,740,427,215
CFO
4.63b
-11.52%
44,650,4204,838,79324,408,045142,409,7290494,028,978465,791,7571,309,515,400983,274,765406,577,7313,444,038,7763,058,568,9731,544,108,8162,449,646,8022,797,944,6251,661,132,7993,669,562,8315,654,954,4465,228,937,0844,626,714,790
Dividend
Jun 06, 20240.42 CNY/sh

Profile

MeiHua Holdings Group Co.,Ltd provides amino acid nutrition and health solutions. Its products include food additives, including sodium glutamate, natamycin, disodium 5'-ribonucleotide, disodium inosinate, xanthan gum, pullulan, and trehalose; condiments, such as monosodium glutamate (MSG); amino acid for feed comprising valine, L-lysine sulphate and HCL, L-threonine, L-tryptophane, corn gluten meal for feedstuffs, corn husk powder, corn fiber feed, and boutique MSG residue. The company also provides pharmaceutical amino acids consisting of L-glutamine, L-leucine, L-isoleucine, L-valine, BCAA, L-proline, inosine, vernine, and adenosine; colloids; enteric, cellulose, gelatin, and pullulan capsules; and fertilizers, which include soil conditioners. MeiHua Holdings Group Co.,Ltd was founded in 2002 and is headquartered in Langfang, China.
URL
http://www.meihuagrp.com/
IPO date
Feb 17, 1995
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
25,069,288
-9.69%
27,760,612
-0.63%
27,937,153
22.33%
Cost of revenue
20,904,656
23,161,721
21,790,667
Unusual Expense (Income)
NOPBT
4,164,633
4,598,891
6,146,486
NOPBT Margin
16.61%
16.57%
22.00%
Operating Taxes
609,033
542,186
746,483
Tax Rate
14.62%
11.79%
12.14%
NOPAT
3,555,599
4,056,705
5,400,003
Net income
2,740,427
-13.85%
3,180,950
-27.81%
4,406,242
83.42%
Dividends
(1,177,370)
(1,216,830)
Dividend yield
4.11%
3.88%
Proceeds from repurchase of equity
(896,190)
BB yield
3.13%
Debt
Debt current
1,734,833
1,543,869
1,335,928
Long-term debt
1,352,064
2,005,144
3,686,049
Deferred revenue
381,021
384,988
429,899
Other long-term liabilities
42,938
441,377
10,500
Net debt
(1,932,828)
(2,420,722)
(596,483)
Cash flow
Cash from operating activities
4,626,715
5,228,937
5,654,954
CAPEX
(1,333,258)
Cash from investing activities
(1,540,361)
Cash from financing activities
(3,140,355)
FCF
3,081,016
4,193,038
4,940,149
Balance
Cash
4,873,090
5,241,073
4,509,225
Long term investments
146,636
728,661
1,109,236
Excess cash
3,766,261
4,581,704
4,221,603
Stockholders' equity
13,223,429
13,130,307
11,677,690
Invested Capital
14,317,555
13,569,111
14,382,219
ROIC
25.50%
29.03%
38.79%
ROCE
23.00%
25.31%
32.72%
EV
Common stock shares outstanding
2,915,348
3,000,896
3,081,288
Price
10.03
5.03%
9.55
-6.19%
10.18
32.72%
Market cap
29,240,941
2.03%
28,658,556
-8.64%
31,367,513
32.79%
EV
27,308,113
26,237,835
30,771,030
EBITDA
5,489,326
5,977,414
7,529,947
EV/EBITDA
4.97
4.39
4.09
Interest
80,472
126,554
149,374
Interest/NOPBT
1.93%
2.75%
2.43%